MedTrace Logo

Inflammatory Index as a Predictor for Endometrial Cancer: an Observational Study

NCT05657483 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 128

Last updated 2024-04-17

No results posted yet for this study

Summary

It is a prospective observational trial. Primary goal is identification of an association between alteration of systemic inflammation indices, such as neutrophil-to-lymphocyte ratio (NLR), platelet-t- lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (MRL) and patients risk classification according to European Guidelines.

The population is represented by all women being admitted to the Gynecology Ward, through Emergency, who are affected by endometrial cancer. Participants will undergo surgery, and freely express their consent to participate in the study.

Conditions

  • Endometrial Neoplasms
  • Inflammatory Response

Interventions

DIAGNOSTIC_TEST

Venous blood sample

Blood chemistry tests: neutrophil; lymphocyte; monocyte; platelet counts.

OTHER

Surgical staging of endometrial cancer

Endometrial, adnexal, and lymphoid tissue samples.

Sponsors & Collaborators

  • University of Campania Luigi Vanvitelli

    lead OTHER

Principal Investigators

  • Carlo Ronsini, MD · University of Campania Luigi Vanvitelli

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-10
Primary Completion
2024-12-10
Completion
2024-12-10

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05657483 on ClinicalTrials.gov